A detailed history of Cm Management, LLC transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Cm Management, LLC holds 325,000 shares of ASRT stock, worth $302,250. This represents 0.32% of its overall portfolio holdings.

Number of Shares
325,000
Previous 350,000 7.14%
Holding current value
$302,250
Previous $434,000 11.75%
% of portfolio
0.32%
Previous 0.4%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.07 - $1.75 $26,750 - $43,750
-25,000 Reduced 7.14%
325,000 $383,000
Q2 2024

Aug 01, 2024

BUY
$0.75 - $1.31 $3,750 - $6,550
5,000 Added 1.45%
350,000 $434,000
Q4 2023

Feb 12, 2024

BUY
$1.02 - $2.57 $180,907 - $455,815
177,360 Added 105.8%
345,000 $369,000
Q3 2023

Nov 07, 2023

BUY
$2.52 - $5.69 $359,452 - $811,621
142,640 Added 570.56%
167,640 $429,000
Q2 2023

Aug 04, 2023

BUY
$5.0 - $7.66 $125,000 - $191,500
25,000 New
25,000 $136,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $44.8M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Cm Management, LLC Portfolio

Follow Cm Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cm Management, LLC with notifications on news.